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Abstract 
Crimean-Congo hemorrhagic fever and dengue hemorrhagic fever are endemic in Pakistan. However, the overlap of geographic distribution 
and early clinical features between the two conditions make a reliable diagnosis difficult in the initial stage of illness. A 16-year-old boy 
presented with a history of hematemesis and high-grade fever. A preliminary diagnosis of dengue hemorrhagic fever was made and 
supportive treatment was instituted; however, the patient continued to deteriorate clinically. Dengue IgM antibody testing was negative on 
the third day of admission. Qualitative polymerase chain reaction test for Crimean-Congo hemorrhagic fever viral RNA was sent but the 
patient expired shortly after the results became available on the sixth day of admission. Considerable resources had to be expended on contact 
tracing and administration of ribavirin prophylaxis to all the health-care workers who had come in contact with the patient. It is crucial that 
Crimean-Congo hemorrhagic fever be recognized and treated at an early stage because of longer term financial and health implications for 
contacts such as health-care workers in the setting of a developing country. Increased surveillance of dengue and Crimean-Congo 
hemorrhagic fever cases is warranted for the derivation of reasonably reliable, cost-effective and prompt predictors of disease diagnosis. 
These predictors can help guide future decisions in the management of similar cases. Ultimately, such a strategy may translate into better cost 
containment in resource-poor settings. Institution of ribavirin prophylaxis in selected patients also merits consideration. 
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Introduction 
Crimean-Congo Hemorrhagic Fever (CCHF) 
virus (genus Nairovirus, family Bunyaviridae) is an 
enveloped virus with a genome consisting of three 
segments of single-stranded RNA of negative 
polarity [1]. This zoonotic virus is transmitted either 
through bite of the tick vector, mainly Hyalomma 
spp., or via direct contact with blood or tissues of 
viremic animals or humans [2]. The infection 
typically affects the reticuloendothelial system and 
causes activation of cytokine cascades in the body. 
This, in turn, leads to increased vascular permeability 
in the victims, ultimately culminating in hemorrhage 
and shock. As the disease evolves, multiple organ 
systems such as hematopoietic, neurologic, and 
pulmonary systems become involved [3,4].   
On the other hand, dengue virus belongs to the 
Flavivirus family and is transmitted through the bite 
of Aedes mosquitoes. The virus has four distinct 
serotypes. A person infected by one serotype 
develops life-long immunity to that particular 
serotype; however, infection by any of the other three 
seroptypes will have devastating consequences for 
that individual due to the phenomenon of “antibody 
enhancement” [5,6]. Dengue virus infection can 
manifest along a wide clinical spectrum including 
dengue fever (DF), dengue hemorrhagic fever (DHF) 
and dengue shock syndrome (DSS). DF patients 
present with fever, myalgias and morbilliform rash. 
In DHF, patients additionally have hemorrhagic 
manifestations while DSS patients have circulatory 
failure as a predominant feature [6]. The underlying 
pathophysiologic basis for the signs and symptoms of 
DHF and DSS is an increase in the permeability of 
the vasculature [5].  
CCHF was first reported in the Crimea, Russia in 
1944 [7]. Since then outbreaks have been described 
from various regions of the Middle East as well as 
Pakistan [8]. CCHF is endemic in Pakistan and 
multiple healthcare associated outbreaks have also 
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been reported since the detection of the first case in 
1976 [8]. Although outbreaks of CCHF in Pakistan 
have classically occurred in rural Balochistan, CCHF 
cases have also occurred in Karachi in recent times 
[1]. CCHF cases in Pakistan have mainly occurred in 
the months of October and November [1]. This time 
period roughly corresponds to the Islamic festival of 
Eid-ul-Azha, celebrated on days 10 to 13 of the last 
month of each lunar calendar year, when large flocks 
of sacrificial animals are brought into the cities from 
the rural areas of Pakistan [4]. 
DHF was first recognized in Asia in the 1950s 
[9]. The first major outbreak of DF in Karachi 
occurred in 1994 [5]. Since then this cosmopolitan 
city has experienced a few outbreaks of this arboviral 
fever, the most recent of which occurred in 2005–
2006. During this epidemic, heavy morbidity and 
mortality burden was reported [10,11]. The case 
fatality rate incurred from CCHF has been reported to 
be considerably higher (15 – 100%) as compared to 
DF (the case fatality rate for dengue shock syndrome 
and dengue hemorrhagic fever is around 3% – 5 % in 
Pakistan) [8,12-15].    
The overlap of the geographic distribution and 
the similarity of the initial presentation of DF and 
CCHF make it difficult to reliably differentiate the 
two conditions, especially in the initial stages of the 
illness. Although conclusive, laboratory tests, 
particularly molecular-based tests, are not 
ubiquitously available in Pakistan. Such tests are also 
expensive and require time for completion. Patients, 
therefore, must be managed initially on clinical 
suspicion alone until laboratory results become 
available. However, this approach may sometimes 
have important subsequent implications when a 
definitive diagnosis becomes available. We describe 
here a case of CCHF in a young male who was 
initially managed on the suspicion of DHF. 
Considerable resources had to be expended later 
when a diagnosis of CCHF was confirmed in the 
same patient.  
 
Case history 
A 16-year-old male presented to the emergency 
department of Aga Khan University Hospital 
(AKUH) with a recent history of three episodes of 
large quantity hematemesis. He had also had 
intermittent, high-grade fever with chills and rigors 
for five days prior to presentation and multiple 
episodes of non-bilious vomiting and watery 
diarrhoea for two days. The remaining history 
obtained from the patient was unremarkable for tick 
bites, contact with animals, persons with similar 
illness, and recent or remote travel. He was a resident 
of Karachi, Pakistan. 
At admission, he was febrile (38.3°C) and 
moderately dehydrated. He was otherwise 
hemodynamically stable at that time. Physical 
examination did not reveal any cutaneous rash or 
active source of bleeding from mucocutaneous 
surfaces. Remaining general and systemic 
examinations were also unremarkable. Emergent 
management of the patient included fluid 
resuscitation and nasogastric (NG) tube placement. 
The aspirate from the tube revealed a large quantity 
of blood. Laboratory values at this time showed 
thrombocytopenia (10 x 10
9
/L), leucopenia (2 x 
10
9
/L), raised serum creatinine (1.5 mg/dl), and 
raised international normalized ratio (1.5) (Figure 1). 
A preliminary diagnosis of DHF was made and the 
patient was admitted into the special care unit (SCU). 
Fluid resuscitation continued and the initial 
management plan consisting of platelet transfusions 
and broad spectrum antibiotics was followed.  
During the first three days of admission, the 
patient’s vital signs deteriorated, particularly his 
blood pressure and pulse. In addition, his Glasgow 
coma scale (GCS) scores dropped dramatically. He 
was therefore intubated and transferred to the 
intensive care unit (ICU). His chest roentgenogram 
showed bilateral perihilar edema. He developed 
oliguria and his serum creatinine also showed serial 
increments.  Dengue IgM antibody, which had been 
sent to the laboratory on the first day of admission, 
came back negative on the third day of admission. 
Elevated fibrin degradation products (18 mg/l) and 
D-dimer values (3.74 units) indicated development of 
consumption coagulopathy. Qualitative PCR for 
CCHF viral RNA was sent at this time in view of the 
patient’s rapidly deteriorating clinical status and 
negative dengue serology. 
Over the next few days, multi-organ failure 
developed rapidly and he was placed on continuous 
renal replacement therapy (CRRT). He also had an 
episode of atrial fibrillation with rapid ventricular 
rate (190-210 beats/min) requiring synchronized 
cardioversion on the sixth day of admission. PCR for 
CCHF viral RNA returned positive at this time. 
Before any specific measures could be instituted after 
the receipt of this result, the patient became 
bradycardiac and developed pulseless electrical 
activity (PEA). Cardiopulmonary resuscitation (CPR) 
code was initiated; however, it was stopped after 28 
minutes of continuous resuscitative efforts.  
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A meeting of the health-care team with the 
patient’s family was immediately arranged. On 
directed questioning, they revealed that although two 
other members of the patient’s family had 
experienced mild upper respiratory tract symptoms a 
few days ago, they had recovered uneventfully and 
did not have any current health complaints. They 
were counselled to visit the hospital in case any other 
family member developed symptoms.  
Contact tracing of individuals in the hospital was 
also done. Seven doctors and 18 nurses were 
identified and given ribavirin prophylaxis for seven 
days. The total cost of this course for these 
individuals was US $401. Some of these health-care 
professionals also reported adverse effects from the 
prophylactic treatment, including jaundice, nausea, 
and hair loss.  
As soon as the patient had been identified as a 
case of CCHF, he was put in strict isolation per 
CCHF policy developed on the basis of the Centers 
for Disease Control and Prevention (CDC) 
recommendations. Prior to this, we were following 
only standard precautions. After the patient died, his 
body was bathed by the nursing staff, who ensured 
strict isolation in addition to contact and respiratory 
precautions. The cadaver was then carefully wrapped 
in a leak-proof bag. The family was also counselled 
about the hazards of bathing or exposing the body 
any further. They were advised to bury the body 
within the sealed bag.      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
Infectious diseases still play a significant role in 
shaping the morbidity and mortality patterns in the 
developing countries [2]. Physicians in these areas 
stand at crossroads because of the endemic nature 
and non-specific overlapping features of many 
infectious diseases, such as tuberculosis, malaria, 
typhoid, and viral fevers. In Pakistan, viral 
hemorrhagic fevers (VHFs) such as CCHF are 
increasingly recognized as a public health problem 
with immense implications for the already limited 
health-care resources [2]. It is unfortunate that the 
understanding regarding clinical presentations and 
modes of spread of CCHF among health-care 
personnel in Pakistan is poor despite the endemic 
nature of the condition [16]. Similarly, knowledge 
about the basic principles of infection control among 
health-care personnel and hospital administrators is 
lacking [2]. Education of both the public as well as 
health-care professionals about viral hemorrhagic 
fevers should, therefore, be undertaken on an urgent 
footing. 
The delay in reaching a diagnosis of CCHF may 
be due to the prudence of ruling out competing and 
commoner diagnoses as well as the reliance on 
effective laboratory testing in such cases. In addition, 
media has preferentially highlighted DF as an 
emerging health problem when compared to CCHF. 
As mentioned earlier, CCHF cases in Pakistan have 
been increasingly documented around the time of the 
Islamic festival of Eid-ul-Azha in recent years. This 
Figure 1. Serial measurements of the platelets and INR values of the patient during his hospital stay (a single value represents the 
average measurement of that parameter over 24 hours). Primary vertical axis shows INR values while the secondary vertical axis shows 
platelet count. Day 1 corresponds to the day of admission to the hospital.  
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is possibly due to the large flocks of sacrificial 
animals that are brought into the cities from the rural 
areas of Pakistan. The animals are kept in open areas 
or private enclosures and are usually slaughtered 
within the first three days of this Islamic festival [4]. 
Although no formal study has been conducted to 
investigate the burden or presence of Hyalomma ticks 
in Karachi, such a study is certainly warranted in 
view of the increasing number of cases of CCHF 
being reported from the city. It is possible that CCHF 
in this particular case was not suspected initially 
because of lack of this temporal association. In 
addition, history of exposure to livestock or other 
animals and infected individuals may not always be 
readily available from patients [1]. This patient did 
not give any history of exposure to livestock or ticks 
and examination also did not reveal any tick bites. 
All these factors can compositely delay the diagnosis 
and do not bode well for a resource-poor country 
such as Pakistan as far as cost-containment is 
concerned.  
There are considerable overlaps in the clinical 
presentations of both CCHF and DHF. Patients with 
CCHF and DHF are both young (mean age for both 
has been reported to be approximately 26 years). 
Both diseases occur more frequently in males 
[1,14,15]. CCHF cases are frequently encountered in 
the months of October and November in Pakistan. In 
comparison, DHF cases have been reported in the 
months of August, September and October [1,15]. 
This temporal distribution for CCHF has been 
explained on the basis of increased livestock 
movement into cities at the time of Eid-ul-Azha [4]. 
For DHF, the temporal association of these months to 
illness can be explained by the rains of the monsoon 
season in Pakistan in July and August every year, 
when pools of stagnant water serve as important 
breeding hubs for the Aedes mosquitoes [15].  
Patients with CCHF generally present with fever, 
vomiting and bleeding from body orifices (≥ 50% of 
cases); however, petechiae or echymoses are seen 
less commonly (~30%) [1,4]. In comparison, patients 
with DHF present with chills/rigors, vomiting, 
diarrhoea, headaches and abdominal pain [5,6,14]. 
Up to 35% patients with DHF present with mucosal 
bleeding while a morbiliform rash is present in about 
80% of patients [5]. Skin lesions seen in DF are 
usually generalized macular blanchable erythematous 
rash (65%) followed by discrete petechial lesions 
(35%) and palmar erythema (30%) [17]. However, 
other studies from Pakistan have reported a lower 
incidence of skin rash (24%) in patients with DHF. 
The discrepancy has been explained on the basis of 
factors that make detection of the rash difficult, such 
as a short-lived course of the rash, lack of itching, 
and the dark skin of the local population [6]. 
Although this particular patient presented with 
hematemesis and no rash, a diagnosis of DHF was 
made initially on the basis of a negative history for 
tick bites and exposure to livestock.  
Laboratory parameters in patients with DHF and 
CCHF are also generally non-specific as patients with 
both diseases demonstrate thrombocytopenia, 
leucopenia with lymphocytosis, deranged coagulation 
profiles, deranged liver function tests, and elevated 
serum creatinine [1,4,5,13,15]. Although patients 
with CCHF are more likely to have persistent 
thrombocytopenia [1] as compared to patients with 
DHF who experience a nadir in platelet count during 
hospital stay followed by improvement [6], this 
phenomenon needs to be investigated in future 
studies.            
Although we did not administer ribavirin in this 
patient, one possible strategy to consider in the future 
is the institution of ribavirin prophylaxis in selected 
patients. The diagnosis of CCHF is usually dependant 
on laboratory evaluation that is not available until 
after a few days of admission. Ribavirin should be 
given to such selected patients in whom a diagnosis 
of CCHF is strongly suspected on the basis of clinical 
grounds alone or whose clinical features sufficiently 
overlap features with DHF and in whom dengue 
serology is inconclusive. This approach may help 
prevent mortalities in cases similar to ours in the 
future.    
 
Conclusion 
In summary, our case represents a complex 
clinical scenario whereby the patient was initially 
suspected of having DHF, a disease that does not 
require institution of specific measures such as 
contact isolation or use of oral anti-viral agents. 
However, the diagnosis of CCHF was established on 
the sixth day of admission. Although the patient died 
shortly thereafter, considerable resources were spent 
on not only tracking contacts who had been exposed 
by this time but also on administering post-exposure 
prophylaxis to such contacts. The diversion of 
hospital resources towards these measures represents 
a considerable degree of necessary disruption 
undertaken to prevent spread of the disease.  Also, 
CCHF cases may generate considerable stress and 
fear among hospital staff and other contacts [12]. 
Previously, CCHF related deaths in health-care 
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workers have been reported from Pakistan on a few 
occasions [1,8,18]. 
It is vital for clinicians to recognize CCHF at an 
early stage. However, that is not always possible.. 
Improved education of health-care workers and 
improved surveillance of DF and CCHF should be 
ensured in our region so that we can devise 
reasonably reliable, cost-effective and prompt 
predictors of disease diagnosis on the basis of the 
collected data. As this case clearly demonstrates, one 
of the biggest challenges we face in the early 
recognition of CCHF is our location in a dengue-
endemic area.    
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